Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
07 2020
Historique:
received: 29 05 2019
revised: 11 02 2020
accepted: 13 02 2020
pubmed: 31 5 2020
medline: 22 6 2021
entrez: 31 5 2020
Statut: ppublish

Résumé

Donnai-Barrow syndrome (DBS) is an autosomal-recessive disorder characterized by multiple pathologies including malformation of forebrain and eyes, as well as resorption defects of the kidney proximal tubule. The underlying cause of DBS are mutations in LRP2, encoding the multifunctional endocytic receptor megalin. Here, we identified a unique missense mutation R3192Q of LRP2 in an affected family that may provide novel insights into the molecular causes of receptor dysfunction in the kidney proximal tubule and other tissues affected in DBS. Using patient-derived induced pluripotent stem cell lines we generated neuroepithelial and kidney cell types as models of the disease. Using these cell models, we documented the inability of megalin R3192Q to properly discharge ligand and ligand-induced receptor decay in lysosomes. Thus, mutant receptors are aberrantly targeted to lysosomes for catabolism, essentially depleting megalin in the presence of ligand in this affected family.

Identifiants

pubmed: 32471643
pii: S0085-2538(20)30263-5
doi: 10.1016/j.kint.2020.02.021
pmc: PMC7322522
pii:
doi:

Substances chimiques

Ligands 0
Low Density Lipoprotein Receptor-Related Protein-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-167

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Références

Hum Mutat. 1992;1(6):445-66
pubmed: 1301956
Dev Cell. 2012 Feb 14;22(2):268-78
pubmed: 22340494
Nephrol Dial Transplant. 2013 Mar;28(3):585-91
pubmed: 23048173
Biochem J. 1991 Aug 1;277 ( Pt 3):677-82
pubmed: 1872803
Am J Pathol. 1999 Oct;155(4):1361-70
pubmed: 10514418
Am J Physiol Cell Physiol. 2011 Apr;300(4):C723-42
pubmed: 21209361
J Biol Chem. 2002 Jul 12;277(28):25660-7
pubmed: 11964399
Cell Mol Life Sci. 2019 Jan;76(1):179-192
pubmed: 30310934
Nat Genet. 2007 Aug;39(8):957-9
pubmed: 17632512
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1242-1254
pubmed: 28366874
Nat Biotechnol. 2009 Mar;27(3):275-80
pubmed: 19252484
Kidney Int. 2002 Sep;62(3):745-56
pubmed: 12164855
Clin Genet. 2018 Jul;94(1):187-188
pubmed: 29532936
Nat Rev Mol Cell Biol. 2002 Apr;3(4):256-66
pubmed: 11994745
Clin Genet. 2014 Sep;86(3):282-6
pubmed: 23992033
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):76-81
pubmed: 19089858
Pediatr Nephrol. 2015 Jun;30(6):1027-31
pubmed: 25822460
Cell. 1999 Feb 19;96(4):507-15
pubmed: 10052453
J Histochem Cytochem. 2006 Oct;54(10):1115-27
pubmed: 16801528
Dev Cell. 2015 Oct 12;35(1):36-48
pubmed: 26439398
Gene Expr Patterns. 2005 Dec;6(1):69-78
pubmed: 16027047

Auteurs

Julia Flemming (J)

Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.

Maike Marczenke (M)

Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.

Ina-Maria Rudolph (IM)

Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.

Rikke Nielsen (R)

Department of Biomedicine, Faculty of Health Science, Aarhus University, Aarhus C, Denmark.

Tina Storm (T)

Department of Biomedicine, Faculty of Health Science, Aarhus University, Aarhus C, Denmark.

Ilsoe Christensen Erik (IC)

Department of Biomedicine, Faculty of Health Science, Aarhus University, Aarhus C, Denmark.

Sebastian Diecke (S)

Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.

Francesco Emma (F)

Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital - IRCCS, Rome, Italy.

Thomas E Willnow (TE)

Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany; Department of Biomedicine, Faculty of Health Science, Aarhus University, Aarhus C, Denmark. Electronic address: willnow@mdc-berlin.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH